Centre for Tropical Diseases, Sacro Cuore-Don Calabria Hospital, 37024, Negrar, Verona, Italy.
Department of Veterinary Sciences, University of Turin, Grugliasco, 10095, Turin, Italy.
Malar J. 2018 Jan 16;17(1):36. doi: 10.1186/s12936-018-2181-0.
Transfusion-transmitted malaria (TTM) is an accidental Plasmodium infection caused by whole blood or a blood component transfusion from a malaria infected donor to a recipient. Infected blood transfusions directly release malaria parasites in the recipient's bloodstream triggering the development of high risk complications, and potentially leading to a fatal outcome especially in individuals with no previous exposure to malaria or in immuno-compromised patients. A systematic review was conducted on TTM case reports in non-endemic areas to describe the epidemiological characteristics of blood donors and recipients.
Relevant articles were retrieved from Pubmed, EMBASE, Scopus, and LILACS. From each selected study the following data were extracted: study area, gender and age of blood donor and recipient, blood component associated with TTM, Plasmodium species, malaria diagnostic method employed, blood donor screening method, incubation period between the infected transfusion and the onset of clinical symptoms in the recipient, time elapsed between the clinical symptoms and the diagnosis of malaria, infection outcome, country of origin of the blood donor and time of the last potential malaria exposure.
Plasmodium species were detected in 100 TTM case reports with a different frequency: 45% Plasmodium falciparum, 30% Plasmodium malariae, 16% Plasmodium vivax, 4% Plasmodium ovale, 2% Plasmodium knowlesi, 1% mixed infection P. falciparum/P. malariae. The majority of fatal outcomes (11/45) was caused by P. falciparum whilst the other fatalities occurred in individuals infected by P. malariae (2/30) and P. ovale (1/4). However, non P. falciparum fatalities were not attributed directly to malaria. The incubation time for all Plasmodium species TTM case reports was longer than what expected in natural infections. This difference was statistically significant for P. malariae (p = 0.006). A longer incubation time in the recipient together with a chronic infection at low parasite density of the donor makes P. malariae a subtle but not negligible risk for blood safety aside from P. falciparum.
TTM risk needs to be taken into account in order to enhance the safety of the blood supply chain from donors to recipients by means of appropriate diagnostic tools.
输血传播疟疾(TTM)是一种意外的疟原虫感染,由来自疟疾感染供体的全血或血液成分输注给受体引起。受感染的血液输注会直接将疟原虫释放到受体的血液中,引发高风险并发症的发展,并可能导致致命的后果,尤其是在没有疟疾既往接触史或免疫功能低下的患者中。对非流行地区的 TTM 病例报告进行了系统评价,以描述献血者和受血者的流行病学特征。
从 Pubmed、EMBASE、Scopus 和 LILACS 中检索相关文章。从每个选定的研究中提取以下数据:研究区域、献血者和受血者的性别和年龄、与 TTM 相关的血液成分、疟原虫种类、采用的疟疾诊断方法、献血者筛查方法、受血者感染输血与临床症状发作之间的潜伏期、从临床症状到疟疾诊断之间的时间间隔、感染结局、献血者的原籍国和最后一次潜在疟疾接触时间。
在 100 例 TTM 病例报告中检测到了不同频率的疟原虫种类:45%的疟原虫恶性疟、30%的间日疟原虫、16%的卵形疟原虫、4%的诺氏疟原虫、2%的猴疟原虫、1%的混合感染疟原虫恶性疟/间日疟。大多数致命结局(11/45)由恶性疟原虫引起,而其他死亡发生在感染间日疟原虫(2/30)和卵形疟原虫(1/4)的个体中。然而,非恶性疟原虫的死亡并非直接归因于疟疾。所有疟原虫 TTM 病例报告的潜伏期均长于自然感染的预期潜伏期。这种差异在间日疟原虫(p=0.006)中具有统计学意义。受者潜伏期延长,供者慢性感染且寄生虫密度低,使间日疟原虫成为除恶性疟原虫以外血液安全的一个微妙但不容忽视的风险。
需要考虑 TTM 风险,通过适当的诊断工具,加强从献血者到受血者的血液供应链的安全性。